# Aowo Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aowo-biotechnology

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Angel (Feb 26, 2026)
- Investors on record: 1

## About

Founded in 2025 and based in Hangzhou, China, Hangzhou Aowo Biotechnology Co., Ltd., dba Aowo Biotechnology, is a regenerative medicine-focused biotechnology company dedicated to translating advanced stem cell and organoid technologies into clinically relevant applications. In February 2026, Aowo Biotechnology raised Angel funding from new investor FIRHealth Capital.
The company focuses on stem cell technologies, organoid R&D, and the construction of translational medicine platforms, supporting preclinical research and future clinical development in regenerative and precision medicine.
Aowo Biotechnology’s revenue is generated from technology service contracts and research collaborations, platform-based preclinical testing and translational research services, and future commercialization of regenerative medicine products derived from stem cell and organoid technologies.

## Funding rounds

- Angel, Feb 26, 2026 — FIRHealth Capital

## Investors

- FIRHealth Capital (https://capitalatlas.ai/funds/firhealth-capital) — Angel